FRANCE – Sanofi has announced the acquisition of Origimm Biotechnology, an Austrian privately held biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing…
Read MoreSanofi acquires Origimm Biotechnology to develop acne vaccine
